Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taiwan Says 23 Million Using $3.68 Billion In Covered Drugs

This article was originally published in PharmAsia News

Executive Summary

Taiwan counts 23 million of its people consuming nearly $3.68 billion worth of drugs a year, and that does not include drugs not covered by national insurance. The nation's Bureau of National health Insurance said the consumption also continues to increase, with cardiovascular-disease drugs rising the fastest. Among them are amiodipine, losartan and valserian, all for lowering blood pressure and costing the government $572 million. Atorvastatin and other drugs for lowering cholesterol cost the national health-insurance plan $165 million. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071150

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel